Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Sensei Biotherapeutics In...

    NASDAQ: SNSE · Real-Time Price · USD
    7.27
    0.72 (10.99%)
    At close: Jun 18, 2025, 3:59 PM
    7.11
    -2.20%
    After-hours: Jun 18, 2025, 05:34 PM EDT

    Sensei Biotherapeutics Statistics

    Share Statistics

    Sensei Biotherapeutics has 25.21M shares outstanding. The number of shares has increased by 0.28% in one year.

    Shares Outstanding

    n/a
    		 25.21M

    Shares Change (YoY)

    n/a
    		 0.28%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 9.4%

    Shares Floating

    n/a
    		 16.52M

    Failed to Deliver (FTD) Shares

    n/a
    		 840

    FTD / Avg. Volume

    n/a
    		 0.03%

    Short Selling Information

    The latest short interest is 197.19K, so 0.78% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 197.19K

    Short % of Shares Out

    n/a
    		 0.78%

    Short % of Float

    n/a
    		 1.16%

    Short Ratio (days to cover)

    n/a
    		 1.78

    Valuation Ratios

    The PE ratio is -0.41 and the forward PE ratio is -0.43. Sensei Biotherapeutics's PEG ratio is 0.25.

    PE Ratio

    n/a
    		 -0.41

    Forward PE

    n/a
    		 -0.43

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.8

    PB Ratio

    n/a
    		 0.32

    P/FCF Ratio

    n/a
    		 -0.5

    PEG Ratio

    n/a
    		 0.25
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Sensei Biotherapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 7.7, with a Debt / Equity ratio of 0.1.

    Current Ratio

    n/a
    		 7.7

    Quick Ratio

    n/a
    		 7.7

    Debt / Equity

    n/a
    		 0.1

    Debt / EBITDA

    n/a
    		 -0.12

    Debt / FCF

    n/a
    		 -0.15

    Interest Coverage

    n/a
    		 -362.38

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-2,154,071.43

    Employee Count

    n/a
    		 14

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -97.21% in the last 52 weeks. The beta is 0.1, so Sensei Biotherapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.1

    52-Week Price Change

    n/a
    		 -97.21%

    50-Day Moving Average

    n/a
    		 7.05

    200-Day Moving Average

    n/a
    		 9.16

    Relative Strength Index (RSI)

    n/a
    		 47.31

    Average Volume (20 Days)

    n/a
    		 2,718,522

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -32.61M

    Net Income

    n/a
    		 -30.16M

    EBITDA

    n/a
    		 -32.61M

    EBIT

    n/a
    		 -30.25M

    Earnings Per Share (EPS)

    n/a
    		 -1.2
    Full Income Statement

    Balance Sheet

    The company has 9.99M in cash and 3.85M in debt, giving a net cash position of 6.15M.

    Cash & Cash Equivalents

    n/a
    		 9.99M

    Total Debt

    n/a
    		 3.85M

    Net Cash

    n/a
    		 6.15M

    Retained Earnings

    n/a
    		 -262.05M

    Total Assets

    n/a
    		 38.27M

    Working Capital

    n/a
    		 30.45M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -24.67M and capital expenditures -146K, giving a free cash flow of -24.82M.

    Operating Cash Flow

    n/a
    		 -24.67M

    Capital Expenditures

    n/a
    		 -146K

    Free Cash Flow

    n/a
    		 -24.82M

    FCF Per Share

    n/a
    		 -0.99
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    SNSE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for SNSE is $90, which is 27172.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $90

    Price Target Difference

    n/a
    		 27172.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Jun 17, 2025. It was a backward split with a ratio of 1:20.

    Last Split Date

    n/a
    		 Jun 17, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:20

    Scores

    Altman Z-Score

    n/a
    		 -10.71

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist